Ann M. Leen is CSO at Allovir, Inc. (ALVR). They have made 7 open-market trades across 1 company since 2021, most recently 2023-02-02.
CIK 0001763026
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ALVR | 65,256 | $640K |
Shares reported on the most recent Form 4, priced at the 2023-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALVR | SELL | 2021-11-12 | 2021-11-16 | $22.17 | $917K | -16.8% | -30.8% | -59.5% |
| ALVR | SELL | 2021-05-10 | 2021-05-10 | $22.75 | $3.4M | +6.7% | +6.2% | +2.9% |
| ALVR | SELL | 2021-03-16 | 2021-03-18 | $30.00 | $91K | -17.6% | -16.3% | -27.4% |
| ALVR | SELL | 2021-03-01 | 2021-03-03 | $38.70 | $737K | -21.8% | -32.2% | -38.0% |
| ALVR | SELL | 2021-02-19 | 2021-02-23 | $41.50 | $1.4M | -20.8% | -43.3% | -44.2% |
| ALVR | SELL | 2021-02-18 | 2021-02-19 | $40.81 | $110K | -10.8% | -38.5% | -46.6% |
| ALVR | SELL | 2021-02-16 | 2021-02-18 | $41.27 | $277K | -8.6% | -38.2% | -49.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.